Polypharmacy and mortality among nursing home residents with advanced cognitive impairment: results from the SHELTER study.

@article{Onder2013PolypharmacyAM,
  title={Polypharmacy and mortality among nursing home residents with advanced cognitive impairment: results from the SHELTER study.},
  author={Graziano Onder and Rosa Liperoti and Andrea Dawn Foebel and Daniela Fialov{\'a} and Eva Topinkov{\'a} and Henri{\"e}tte van der Roest and Jacob Gindin and Alfonso Jos{\'e} Cruz-Jentoft and Massimo Fini and Giovanni Gambassi and Roberto Bernabei},
  journal={Journal of the American Medical Directors Association},
  year={2013},
  volume={14 6},
  pages={450.e7-12}
}
INTRODUCTION Older adults with advanced cognitive impairment have a limited life expectancy and the use of multiple drugs is of questionable benefit in this population. The aim of the present study was to assess if, in a sample of nursing home (NH) residents with advanced cognitive impairment, the effect of polypharmacy on mortality differs depending on estimated life expectancy. METHODS Data were from the Services and Health for Elderly in Long TERm care (SHELTER) project, a study collecting… CONTINUE READING